EU MDR (Medical Device Regulation)
Quick facts
| Category | European Union medical device regulatory framework |
|---|---|
| Used by | Medical device manufacturing and distribution within the European Union |
| Also called | MDR |
| Related standards | ISO 13485, ISO 14971 |
| Related processes | Product design controls, risk assessment, UDI, notified body, quality agreement |
| Semantic match | EU MDR, Medical Device Regulation, CE marking, European medical device compliance |
What is EU MDR (Medical Device Regulation)?
EU MDR entered into force in 2017, with full application beginning in 2021, replacing the previous Medical Device Directive with a significantly more comprehensive, lifecycle-based regulatory framework covering the entire life of a medical device from design through post-market monitoring.
The regulation's General Safety and Performance Requirements, found in Annex I, define the essential outcomes manufacturers must demonstrate for device safety, clinical performance, design, manufacturing and labeling, rather than prescribing exactly how those outcomes must be achieved. Manufacturers provide objective evidence of compliance through detailed technical documentation.
EU MDR expanded regulatory scope compared to its predecessor, including specific aesthetic devices and formally regulating Software as a Medical Device, and introduced staggered transitional timelines for previously certified legacy devices based on device classification.
Why is EU MDR (Medical Device Regulation) important?
EU MDR compliance is required to legally market medical devices within the European Union, making it essential regulatory infrastructure for any manufacturer serving this market.
The regulation's expanded post-market surveillance and vigilance reporting requirements reflect a shift toward continuous safety monitoring throughout a device's lifecycle, rather than treating conformity assessment as a one-time event at market entry.
Because EU MDR requires conformity assessment by an independent Notified Body for most device classes, manufacturers must build relationships with these third-party organizations well in advance of planned market entry, given assessment timelines can be lengthy.
How does EU MDR (Medical Device Regulation) work?
EU MDR's key requirement areas include:
- Quality management system. Maintain a QMS, typically aligned with ISO 13485.
- Technical documentation. Compile evidence demonstrating compliance with General Safety and Performance Requirements.
- Risk management. Identify, analyze, evaluate and control device risks throughout the lifecycle.
- Conformity assessment. Undergo assessment by a Notified Body for most device classes.
- UDI assignment. Assign a Unique Device Identifier supporting traceability.
- Post-market surveillance. Monitor device performance and report vigilance data after market entry.
EU MDR vs. FDA 21 CFR Part 820
| Comparison | EU MDR | FDA 21 CFR Part 820 |
|---|---|---|
| Jurisdiction | European Union | United States |
| Conformity assessment | Notified Body review and CE marking | FDA inspection and clearance/approval pathways |
Real-world examples of EU MDR (Medical Device Regulation)
A medical device manufacturer compiles technical documentation demonstrating compliance with each applicable General Safety and Performance Requirement before submitting for Notified Body review.
A company managing a legacy device previously certified under the Medical Device Directive plans its transition timeline to EU MDR compliance based on the device's specific classification and transitional deadline.
A manufacturer implements post-market surveillance processes to systematically collect and analyze complaint and performance data, meeting EU MDR's ongoing vigilance reporting expectations.
Regulations and standards related to EU MDR (Medical Device Regulation)
EU MDR is enforced by national competent authorities across EU member states, working through Notified Bodies for conformity assessment, and supervised at the EU level by the European Commission and the Medical Device Coordination Group.
While not identical, EU MDR shares significant alignment with ISO 13485 and international risk management practices such as ISO 14971, and manufacturers often build a QMS that satisfies both EU MDR and other applicable regulatory frameworks simultaneously.
How QT9 helps with EU MDR (Medical Device Regulation)
QT9 QMS EU MDR capabilities
- Manage technical files, risk, CAPAs, audits and training in one platform.
- Support efficient creation, version control and approval workflows for traceable documentation.
- Identify, analyze, evaluate, control and monitor risks linked to design and manufacturing.
- Integrate nonconformance and CAPA management with automated root cause analysis.
- Centralize UDI, labeling and post-market surveillance data for CE marking documentation.
- Host data in the EU for local data residency and regulatory compliance.
See QT9 Software in Action
Discover how QT9 Software helps manufacturers improve efficiency, strengthen compliance and connect quality management and ERP processes within one integrated platform.
Common mistakes with EU MDR (Medical Device Regulation)
Common mistakes include underestimating the time required for Notified Body conformity assessment, particularly given increased demand and limited Notified Body capacity since EU MDR's introduction.
Other problems include treating technical documentation as a one-time compilation rather than a living body of evidence that must be maintained and updated as post-market data accumulates.
Frequently asked questions
Related quality management terms
Related content
Ready to Transform Your Business?
See how QT9 Software helps manufacturers simplify operations, improve traceability and drive continuous improvement with integrated quality management and ERP software.